Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL5571243

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](c2cc(N3CCN(Cc4ccc(-c5c6ncn(CC7(O)CCN(C(=O)C[C@@H](C)c8ccccc8)CC7)c(=O)c6nn5C)cc4)CC3)no2)C(C)C)cc1

Basic Information

ChEMBL ID CHEMBL5571243
Phase Preclinical
Structure Type MOL
InChI Key ZCAILYLCWKWLIC-APKAJERZSA-N
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
5
Publications
0
Known Names

Molecular Properties

1064.3
MW (Da)

Drug Information

Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C58H69N11O7S
MW 1064.33

Activity Summary

IC50 2 meas. best 9.3

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
RS4-11
CHEMBL2366159
IC50 9.3 9.3 0.5 1
REH
CHEMBL2366320
IC50 8.08 8.08 8.3 1

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
39028938 10.1021/acs.jmedchem.4c01134 RS4-11 24
39028938 10.1021/acs.jmedchem.4c01134 von Hippel-Lindau disease tumor suppressor/Ubiquitin carboxyl-terminal hydrolase 7 14
39028938 10.1021/acs.jmedchem.4c01134 Unchecked 2
39028938 10.1021/acs.jmedchem.4c01134 ADMET 2
39028938 10.1021/acs.jmedchem.4c01134 REH 1

Data from ChEMBL 36 via Core Engine